Stocks · Health care · Pharmaceutical Preparations

Aldeyra Therapeutics, Inc.

ALDX Clue Score54
United States Fiscal year ends December CIK 0001341235

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Gary M. Phillips
7 Sep 2023
Director
Exercised, kept
5,437
$0.55
$3.00K
Todd C Brady
7 Sep 2023
President and CEO
Exercised, kept
48,021
$0.55
$26.51K
Todd C Brady
7 Sep 2023
President and CEO
Exercised, kept
32,953
$0.55
$18.19K
Todd C Brady
7 Sep 2023
President and CEO
Exercised, kept
192,084
$0.55
$106.03K
Neal Walker
22 Aug 2023
Director
Exercised, kept
9,604
$0.55
$5.30K
Ben Bronstein
27 Jun 2023
Director
Exercised, kept
9,604
$0.55
$5.30K

What was left out

Form 4 filings counted 151
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 2,657,507
Sales filed before the plan box existed 2
History held since 5 May 2014